Loading...

PSIX The timing of insider sales is a serious question mark

Published
03 Dec 25
n/a
n/a
composite32's Fair Value
n/a
Loading
1Y
94.6%
7D
3.6%

Author's Valuation

US$37.3845.7% overvalued intrinsic discount

composite32's Fair Value

1. Financial Forensic Analysis: Quality of Earnings

PSI's Q3 2025 financial results, while appearing bright on the surface, reveal a profit statement supported by accounting techniques that lacks cash generation capacity upon closer examination.

1.1. Impact of Non-Cash Profit Items: Deferred Tax Asset (DTA)

A significant component of the company's Q3 2025 net profit of $27.6 million did not come from operating activities.

DTA Release: The company released a $7.0 million "Valuation Allowance on Deferred Tax Assets" in the quarter, reflecting it in the income statement and recording a tax benefit of $0.9 million. This transaction is purely an accounting estimate and does not contribute to the company's cash position.

Adjusted Earnings: After adjusting for this $7 million impact, the company's pre-tax operating profit and net income are significantly lower. Investors should factor in this "bubble" when calculating P/E multiples. If this adjustment is not made, the stock appears artificially cheap.

1.2. Working Capital: The Cost of Growth

The 62% increase in sales is positive, but the damage these sales have caused to the balance sheet is unsustainable.

Receivables Quality: Accounts Receivable increased from $68.9 million at the end of 2024 to $87.9 million in Q3 2025. More significant, however, is the mismatch between the growth rate of receivables and cash collections. The deterioration in Receivable Turnover suggests that the company is granting customers longer terms to increase sales or that the quality of collections has deteriorated.

Inventory Bloat: Inventory increased by 62% in nine months, from $93.8 million to $152.2 million. While management explained this as a "production ramp-up," the faster inventory growth than sales creates the risk of unsold product or a "working capital trap." Cash is tied up in warehouses waiting for engines.

Contract Assets: Contract assets decreased from $21.4 million to $13.2 million. While this decrease indicates some invoicing, the extent of "Unbilled Revenue" on the income statement raises questions about the proportion of revenue that is accrued.

1.3. Cash Flow Analysis

The clearest indicator of earnings quality is the relationship between "Net Cash Provided by Operating Activities" (CFO) and "Net Income."

Ratio Analysis: In the first nine months of 2025, the company reported a net profit of $45.9 million. However, net cash provided by operating activities during the same period was only $28.7 million. The CFO/Net Income ratio is 0.62.

What should we understand?: A ratio below 1.0 indicates that reported profits are not being converted into cash. The company appears to be making a profit, but is burning cash to finance its operations. This indicates that the company may need external funding (debt or capital increases) to finance its growth.

How well do narratives help inform your perspective?

Disclaimer

The user composite32 holds no position in NasdaqCM:PSIX. Simply Wall St has no position in any of the companies mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The author of this narrative is not affiliated with, nor authorised by Simply Wall St as a sub-authorised representative. This narrative is general in nature and explores scenarios and estimates created by the author. The narrative does not reflect the opinions of Simply Wall St, and the views expressed are the opinion of the author alone, acting on their own behalf. These scenarios are not indicative of the company's future performance and are exploratory in the ideas they cover. The fair value estimates are estimations only, and does not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that the author's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives